PMID- 24028188 OWN - NLM STAT- MEDLINE DCOM- 20140409 LR - 20211021 IS - 1529-8027 (Electronic) IS - 1085-9489 (Print) IS - 1085-9489 (Linking) VI - 18 IP - 3 DP - 2013 Sep TI - Cdc42 GTPases facilitate TNF-alpha-mediated secretion of CCL2 from peripheral nerve microvascular endoneurial endothelial cells. PG - 199-208 LID - 10.1111/jns5.12032 [doi] AB - Trafficking of autoreactive leukocytes across the blood-nerve barrier and into peripheral nerves is an early pathological hallmark of Guillain-Barre syndrome (GBS). Tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, promotes transendothelial migration by upregulating endothelial expression of inflammatory mediators, including CCL2, a chemokine implicated in GBS. We sought to determine the mechanism by which TNF-alpha induces expression and secretion of CCL2 from peripheral nerve microvascular endoneurial endothelial cells (PNMECs). Expression of CCL2 mRNA and protein in quiescent PNMEC cultures was minimal. In contrast, cultures treated with TNF-alpha exhibited increased CCL2 mRNA and protein content, as well as protein secretion. Simvastatin significantly attenuated TNF-alpha-induced CCL2 secretion without affecting CCL2 mRNA or protein expression. Co-incubation with geranylgeranyl pyrophosphate, but not farnesyl pyrophosphate, prevented the effect of simvastatin. By comparison, inhibiting protein isoprenylation with GGTI-298, but not FTI-277, mimicked the effect of simvastatin and significantly attenuated transendothelial migration in vitro. Inhibition of the monomeric GTPase Cdc42, but not Rac1 or RhoA-C, attenuated TNF-alpha-mediated CCL2 secretion. TNF-alpha-mediated trafficking of autoreactive leukocytes into peripheral nerves during GBS may proceed by a mechanism that involves Cdc42-facilitated secretion of CCL2. CI - Published 2013. This article is a U.S. Government work and is in the public domain in the USA. FAU - Langert, Kelly A AU - Langert KA AD - Research Service, Department of Veterans Affairs, Edward Hines, Jr. VA Hospital, Hines, IL, USA; Program of Neuroscience. FAU - Von Zee, Cynthia L AU - Von Zee CL FAU - Stubbs, Evan B Jr AU - Stubbs EB Jr LA - eng GR - R03 NS061033/NS/NINDS NIH HHS/United States GR - 1R03NS061033/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. PL - United States TA - J Peripher Nerv Syst JT - Journal of the peripheral nervous system : JPNS JID - 9704532 RN - 0 (Chemokine CCL2) RN - 0 (Enzyme Inhibitors) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - 0 (Polyisoprenyl Phosphates) RN - 0 (RNA, Messenger) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.6.5.2 (cdc42 GTP-Binding Protein) RN - N21T0D88LX (geranylgeranyl pyrophosphate) SB - IM MH - Analysis of Variance MH - Animals MH - Cells, Cultured MH - Chemokine CCL2/genetics/*metabolism MH - Dose-Response Relationship, Drug MH - Endothelial Cells/*drug effects/*metabolism MH - Enzyme Inhibitors/pharmacology MH - Enzyme-Linked Immunosorbent Assay MH - Humans MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology MH - Leukemia, Monocytic, Acute/pathology MH - Peripheral Nerves/*cytology MH - Polyisoprenyl Phosphates/pharmacology MH - Prenylation/drug effects MH - RNA, Messenger/metabolism MH - Rats MH - Transendothelial and Transepithelial Migration/drug effects MH - Tumor Necrosis Factor-alpha/*pharmacology MH - cdc42 GTP-Binding Protein/genetics/*metabolism PMC - PMC3785369 MID - NIHMS511666 OTO - NOTNLM OT - GTPases OT - cytokine OT - endothelial OT - microvascular OT - peripheral nerve EDAT- 2013/09/14 06:00 MHDA- 2014/04/10 06:00 PMCR- 2014/09/01 CRDT- 2013/09/14 06:00 PHST- 2013/02/07 00:00 [received] PHST- 2013/05/01 00:00 [revised] PHST- 2013/07/22 00:00 [accepted] PHST- 2013/09/14 06:00 [entrez] PHST- 2013/09/14 06:00 [pubmed] PHST- 2014/04/10 06:00 [medline] PHST- 2014/09/01 00:00 [pmc-release] AID - 10.1111/jns5.12032 [doi] PST - ppublish SO - J Peripher Nerv Syst. 2013 Sep;18(3):199-208. doi: 10.1111/jns5.12032.